Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Silgan Holdings Inc filings on SEC EDGAR ↗
For the nine months ended September 30, 2026, Silgan Holdings reported net sales of $5.24 billion, a slight increase from $5.01 billion in the prior year, while net income decreased to $243.8 million from $270.2 million. The company experienced higher rationalization charges and increased cost of goods sold, which impacted overall profitability despite the growth in sales.
Silgan Holdings reported third quarter 2026 net sales of $2.04 billion and record adjusted EPS of $1.31, which was at the high end of its guidance range. The company highlighted double-digit growth in dispensing products for pharma markets and mid-single digit growth in fragrance markets. Based on the strong performance, Silgan raised the midpoint of its full-year earnings estimate.
Term
3 years
“As Silgan embarks upon the next chapter in our value creation journey through our recently announced portfolio transformation, we remain steadfast in our commitment to compete and win in the markets we serve by meeting the unique needs of our customers and being the best at what we do.”
Adam Greenlee, President and CEO
“We are pleased to have delivered record third quarter adjusted EPS that grew 7% year over year and was at the top of our estimated range for the quarter. The strength of our results continued to exhibit the success of our strategic growth initiatives, the long-term resilience of our business through challenging customer and end market conditions, and the power of our operating model.”